Search research articles
Contact Us
Filters
Showing results (51-60 of 98) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2013
The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression
Marion A Salvador, Julien Wicinski, Olivier Cabaud, et al.
BMC Cancer
|
October 17, 2006
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers
Anne Letessier, Fabrice Sircoulomb, Christophe Ginestier, et al.
Stem Cell Reports
|
June 18, 2014
Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells
Sara Lombardi, Gabriella Honeth, Christophe Ginestier, et al.
The American Journal of Pathology
|
October 9, 2002
Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers
Christophe Ginestier, Emmanuelle Charafe-Jauffret, François Bertucci, et al.
Nature Chemistry
|
August 5, 2020
CD44 regulates epigenetic plasticity by mediating iron endocytosis
Sebastian Müller, Fabien Sindikubwabo, Tatiana Cañeque, et al.
Plos One
|
August 22, 2014
Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib
Marine Gilabert, Simon Launay, Christophe Ginestier, et al.
Cancer Research
|
January 13, 2011
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
Suling Liu, Christophe Ginestier, Sing J Ou, et al.
Nature Chemical Biology
|
February 12, 2019
PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling
Agata Nawrotek, Sarah Benabdi, Supaporn Niyomchon, et al.
Cell Stem Cell
|
March 29, 2008
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, et al.
Genes, Chromosomes & Cancer
|
September 28, 2002
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene
Cornel Popovici, Céline Basset, François Bertucci, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 98) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2013
The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression
Marion A Salvador, Julien Wicinski, Olivier Cabaud, et al.
BMC Cancer
|
October 17, 2006
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers
Anne Letessier, Fabrice Sircoulomb, Christophe Ginestier, et al.
Stem Cell Reports
|
June 18, 2014
Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells
Sara Lombardi, Gabriella Honeth, Christophe Ginestier, et al.
The American Journal of Pathology
|
October 9, 2002
Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers
Christophe Ginestier, Emmanuelle Charafe-Jauffret, François Bertucci, et al.
Nature Chemistry
|
August 5, 2020
CD44 regulates epigenetic plasticity by mediating iron endocytosis
Sebastian Müller, Fabien Sindikubwabo, Tatiana Cañeque, et al.
Plos One
|
August 22, 2014
Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib
Marine Gilabert, Simon Launay, Christophe Ginestier, et al.
Cancer Research
|
January 13, 2011
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
Suling Liu, Christophe Ginestier, Sing J Ou, et al.
Nature Chemical Biology
|
February 12, 2019
PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling
Agata Nawrotek, Sarah Benabdi, Supaporn Niyomchon, et al.
Cell Stem Cell
|
March 29, 2008
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, et al.
Genes, Chromosomes & Cancer
|
September 28, 2002
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene
Cornel Popovici, Céline Basset, François Bertucci, et al.
Page
of 10